The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 14, 2024

Filed:

Sep. 22, 2023
Applicant:

Ono Pharmaceutical Co., Ltd., Osaka, JP;

Inventors:

Atsushi Yoshida, Osaka, JP;

Ryuichi Hyakutake, Osaka, JP;

Nozomu Nagashima, Osaka, JP;

Ryosuke Misu, Osaka, JP;

Shohei Mori, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/403 (2006.01); A61P 29/00 (2006.01); C07D 209/52 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); C07D 495/14 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
C07D 495/14 (2013.01); A61P 29/00 (2018.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01);
Abstract

A drug is provided, which containing, as an active ingredient, a compound having ABHD6 inhibitory activity in prevention and/or treatment of a disease associated with ABHD6. A compound of formula (I-A) or a pharmaceutically acceptable salt thereof has ABHD6 inhibitory activity and therefore is useful as a pharmaceutical ingredient having potent ABHD6 inhibitory activity in the prevention and/or treatment of a disease associated with ABHD6: in which all symbols represent the same meaning as the symbols described in the specification.


Find Patent Forward Citations

Loading…